These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8670319)

  • 21. Methotrexate chronotherapy is effective against rheumatoid arthritis.
    To H; Yoshimatsu H; Tomonari M; Ida H; Tsurumoto T; Tsuji Y; Sonemoto E; Shimasaki N; Koyanagi S; Sasaki H; Ieiri I; Higuchi S; Kawakami A; Ueki Y; Eguchi K
    Chronobiol Int; 2011 Apr; 28(3):267-74. PubMed ID: 21452922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravascular tumor necrosis factor alpha blockade reverses endothelial dysfunction in rheumatoid arthritis.
    Cardillo C; Schinzari F; Mores N; Mettimano M; Melina D; Zoli A; Ferraccioli G
    Clin Pharmacol Ther; 2006 Sep; 80(3):275-81. PubMed ID: 16952494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis.
    Capsoni F; Sarzi-Puttini P; Atzeni F; Minonzio F; Bonara P; Doria A; Carrabba M
    Arthritis Res Ther; 2005; 7(2):R250-5. PubMed ID: 15743471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?
    Alivernini S; Tolusso B; Petricca L; Bui L; Di Sante G; Peluso G; Benvenuto R; Fedele AL; Federico F; Ferraccioli G; Gremese E
    Ann Rheum Dis; 2017 Jul; 76(7):1228-1236. PubMed ID: 28119289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor necrosis factor-α inhibitor use is not associated with lipid changes in rheumatoid arthritis.
    Bili A; Morris SJ; Sartorius JA; Kirchner HL; Antohe JL; Dancea S; Wasko MC
    J Rheumatol; 2012 May; 39(5):946-8. PubMed ID: 22467937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical remission following treatment with tumour necrosis factor-alpha antagonists is not accompanied by changes in asymmetric dimethylarginine in patients with rheumatoid arthritis.
    Sandoo A; Dimitroulas T; Toms TE; Hodson J; Veldhuijzen van Zanten JJ; Smith JP; Kitas GD
    Clin Biochem; 2012 Nov; 45(16-17):1399-403. PubMed ID: 22820438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-tumor necrosis factor-alpha therapy and periodontal parameters in patients with rheumatoid arthritis.
    Mayer Y; Balbir-Gurman A; Machtei EE
    J Periodontol; 2009 Sep; 80(9):1414-20. PubMed ID: 19722791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor necrosis factor-alpha production is associated with less body cell mass in women with rheumatoid arthritis.
    Walsmith J; Abad L; Kehayias J; Roubenoff R
    J Rheumatol; 2004 Jan; 31(1):23-9. PubMed ID: 14705214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term efficacy and safety of add-on tacrolimus for persistent, active rheumatoid arthritis despite treatment with methotrexate and tumor necrosis factor inhibitors.
    Naniwa T; Iwagaitsu S; Kajiura M
    Int J Rheum Dis; 2018 Mar; 21(3):673-687. PubMed ID: 29314738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methotrexate Reduced TNF Bioactivity in Rheumatoid Arthritis Patients Treated with Infliximab.
    Dénarié D; Rinaudo-Gaujous M; Thomas T; Paul S; Marotte H
    Mediators Inflamm; 2017; 2017():3708250. PubMed ID: 28352145
    [No Abstract]   [Full Text] [Related]  

  • 31. Cost effectiveness of tumour necrosis factor-alpha inhibitors as first-line agents in rheumatoid arthritis.
    Spalding JR; Hay J
    Pharmacoeconomics; 2006; 24(12):1221-32. PubMed ID: 17129076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolution of imaging findings, laboratory and functional parameters in rheumatoid arthritis patients after one year of treatment with anti-TNF-α agents.
    Detorakis EE; Magkanas E; Lasithiotaki I; Sidiropoulos P; Boumpas DT; Gourtsoyiannis N; Antoniou K; Raissaki M
    Clin Exp Rheumatol; 2017; 35(1):43-52. PubMed ID: 27908307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?
    Askling J; van Vollenhoven RF; Granath F; Raaschou P; Fored CM; Baecklund E; Dackhammar C; Feltelius N; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Rantapää-Dahlqvist S; Saxne T; Klareskog L
    Arthritis Rheum; 2009 Nov; 60(11):3180-9. PubMed ID: 19877027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methotrexate analogues display enhanced inhibition of TNF-α production in whole blood from RA patients.
    van der Heijden JW; Assaraf YG; Gerards AH; Oerlemans R; Lems WF; Scheper RJ; Dijkmans BA; Jansen G
    Scand J Rheumatol; 2014; 43(1):9-16. PubMed ID: 23987246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histological analysis of synovium by treatment of etanercept for rheumatoid arthritis.
    Suzuki Y; Inoue K; Chiba J; Inoue Y; Kanbe K
    Int J Rheum Dis; 2009 Apr; 12(1):7-13. PubMed ID: 20374310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidative burst of neutrophils in patients with rheumatoid arthritis: influence of various cytokines and medication.
    Mur E; Zabernigg A; Hilbe W; Eisterer W; Halder W; Thaler J
    Clin Exp Rheumatol; 1997; 15(3):233-7. PubMed ID: 9177916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
    Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A
    Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
    Rioja I; Hughes FJ; Sharp CH; Warnock LC; Montgomery DS; Akil M; Wilson AG; Binks MH; Dickson MC
    Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The immunomodulatory effects of TNF-α inhibitors on human Th17 cells via RORγt histone acetylation.
    Lin YC; Lin YC; Wu CC; Huang MY; Tsai WC; Hung CH; Kuo PL
    Oncotarget; 2017 Jan; 8(5):7559-7571. PubMed ID: 27926504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral blood expression of nuclear factor-kappab-regulated genes is associated with rheumatoid arthritis disease activity and responds differentially to anti-tumor necrosis factor-alpha versus methotrexate.
    Parker A; Izmailova ES; Narang J; Badola S; Le T; Roubenoff R; Ginsburg GS; Maier A; Coblyn JS; Shadick NA; Weinblatt ME
    J Rheumatol; 2007 Sep; 34(9):1817-22. PubMed ID: 17696278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.